500488 Stock Overview
Operates as a pharmaceutical company in India. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Abbott India Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹27,145.25 |
52 Week High | ₹30,499.90 |
52 Week Low | ₹21,983.40 |
Beta | 0.013 |
11 Month Change | -6.48% |
3 Month Change | -6.37% |
1 Year Change | 13.64% |
33 Year Change | 40.70% |
5 Year Change | 112.95% |
Change since IPO | 4,662.32% |
Recent News & Updates
Recent updates
Shareholder Returns
500488 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -0.7% | -0.2% | 0.3% |
1Y | 13.6% | 40.5% | 27.3% |
Return vs Industry: 500488 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 500488 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
500488 volatility | |
---|---|
500488 Average Weekly Movement | 2.9% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in IN Market | 9.2% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500488 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500488's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
Abbott India Limited Fundamentals Summary
500488 fundamental statistics | |
---|---|
Market cap | ₹577.85b |
Earnings (TTM) | ₹12.85b |
Revenue (TTM) | ₹60.66b |
44.9x
P/E Ratio9.5x
P/S RatioIs 500488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
500488 income statement (TTM) | |
---|---|
Revenue | ₹60.66b |
Cost of Revenue | ₹33.43b |
Gross Profit | ₹27.23b |
Other Expenses | ₹14.39b |
Earnings | ₹12.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 604.57 |
Gross Margin | 44.89% |
Net Profit Margin | 21.18% |
Debt/Equity Ratio | 0% |
How did 500488 perform over the long term?
See historical performance and comparison